141 related articles for article (PubMed ID: 29408173)
1. PTEN in kidney cancer: A review and meta-analysis.
Que WC; Qiu HQ; Cheng Y; Liu MB; Wu CY
Clin Chim Acta; 2018 May; 480():92-98. PubMed ID: 29408173
[TBL] [Abstract][Full Text] [Related]
2. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis.
Tang L; Li X; Gao Y; Chen L; Gu L; Chen J; Lyu X; Zhang Y; Zhang X
PLoS One; 2017; 12(7):e0179437. PubMed ID: 28672019
[TBL] [Abstract][Full Text] [Related]
3. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
[TBL] [Abstract][Full Text] [Related]
4. Association between PTEN and clinical-pathological features of osteosarcoma.
Zhou J; Xiao X; Wang W; Luo Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31270249
[TBL] [Abstract][Full Text] [Related]
5. Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non-small cell lung cancer patients and its impact on survival: A systematic review and meta-analysis.
Zhao Y; Zheng R; Li J; Lin F; Liu L
Thorac Cancer; 2017 May; 8(3):203-213. PubMed ID: 28263037
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value and potential drug target of phosphatase and tensin homolog in breast cancer patients: A meta-analysis.
Xu F; Zhang C; Cui J; Liu J; Li J; Jiang H
Medicine (Baltimore); 2017 Sep; 96(36):e8000. PubMed ID: 28885360
[TBL] [Abstract][Full Text] [Related]
7. Loss of Expression of PTEN is Associated with Worse Prognosis in Patients with Cancer.
Qiu ZX; Zhao S; Li L; Li WM
Asian Pac J Cancer Prev; 2015; 16(11):4691-8. PubMed ID: 26107225
[TBL] [Abstract][Full Text] [Related]
8. Association of the PTEN IVS4 (rs3830675) gene polymorphism with reduced risk of cancer: evidence from a meta-analysis.
Mandal RK; Akhter N; Irshad M; Panda AK; Ali A; Haque S
Asian Pac J Cancer Prev; 2015; 16(3):897-902. PubMed ID: 25735379
[TBL] [Abstract][Full Text] [Related]
9. PTEN expression is associated with the outcome of lung cancer: evidence from a meta-analysis.
Gu J; Ou W; Huang L; Wu J; Li S; Xu J; Feng J; Liu B; Zhou Y
Minerva Med; 2016 Oct; 107(5):342-51. PubMed ID: 27333149
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological parameters and prognostic relevance of miR-21 and PTEN expression in Wilms' tumor.
Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
J Pediatr Surg; 2017 Aug; 52(8):1348-1354. PubMed ID: 28040201
[TBL] [Abstract][Full Text] [Related]
11. Association between PTEN Gene IVS4 polymorphism and risk of cancer: a meta-analysis.
Sun L; Liu J; Yuan Q; Xing C; Yuan Y
PLoS One; 2014; 9(6):e98851. PubMed ID: 24901890
[TBL] [Abstract][Full Text] [Related]
12. The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review.
Lu YM; Cheng F; Teng LS
Sci Rep; 2016 Sep; 6():32723. PubMed ID: 27620353
[TBL] [Abstract][Full Text] [Related]
13. PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature.
Xiao J; Hu CP; He BX; Chen X; Lu XX; Xie MX; Li W; He SY; You SJ; Chen Q
Oncotarget; 2016 Sep; 7(36):57832-57840. PubMed ID: 27506936
[TBL] [Abstract][Full Text] [Related]
14. The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis.
Wang Y; Liu Y; Du Y; Yin W; Lu J
Curr Med Res Opin; 2013 Jun; 29(6):633-42. PubMed ID: 23574264
[TBL] [Abstract][Full Text] [Related]
15. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
16. Impact of PTEN IVS4 Polymorphism (rs3830675) on Cancer Susceptibility: An Updated Meta-analysis.
Wang Y; Yang H; Luo JI; Ge J
Cancer Genomics Proteomics; 2015; 12(5):263-9. PubMed ID: 26417029
[TBL] [Abstract][Full Text] [Related]
17. The association of Phosphatase and tensin homolog (PTEN) deletion and prostate cancer risk: A meta-analysis.
Gao T; Mei Y; Sun H; Nie Z; Liu X; Wang S
Biomed Pharmacother; 2016 Oct; 83():114-121. PubMed ID: 27470558
[TBL] [Abstract][Full Text] [Related]
18. Over-Expression of miR-21 and Lower PTEN Levels in Wilms' Tumor with Aggressive Behavior.
Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
Tohoku J Exp Med; 2017 May; 242(1):43-52. PubMed ID: 28529243
[TBL] [Abstract][Full Text] [Related]
19. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
